MAP2K1 and neuroblastoma: Liraglutide attenuated MG-induced apoptosis in neuroblastoma SH-SY5Y cells through the up-regulations of pro-survival Mcl1 signaling, and Akt and MEK1/2 synthesis (Sharma et al., 2014).